SARS-CoV-2 antibody performances: we need better criteria.

Galli, Claudio; Plebani, Mario

Galli, Claudio; Plebani, Mario.

Galli C; Medical & Scientific Affairs, Abbott Diagnostics, Rome, Italy.
Plebani M; Department of Medicine-DIMED, University of Padova, Padova, Italy.

Clin Chem Lab Med ; 58(12): e303-e305, 2020 09 25.

Article in English | MEDLINE | ID: covidwho-792091

Subject(s)

Antibodies, Viral/blood; Betacoronavirus/immunology; Immunoassay; Antibodies, Viral/immunology; COVID-19; Coronavirus Infections/blood; Coronavirus Infections/diagnosis; Coronavirus Infections/epidemiology; Coronavirus Infections/immunology; Humans; Pandemics; Pneumonia, Viral/blood; Pneumonia, Viral/diagnosis; Pneumonia, Viral/epidemiology; Pneumonia, Viral/immunology; SARS-CoV-2

Keywords

SARS-CoV-2 antibody; motility; sensitivity; specificity

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunoassay / Betacoronavirus / Antibodies, Viral Type of study: Diagnostic study / Observational study Limits: Humans Language: English Journal: Clin Chem Lab Med Journal subject: Chemistry, Clinical / Laboratory Techniques and procedures Year: 2020 Document Type: Article Affiliation country: Cclm-2020-1358

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google